Morgan Stanley Reaffirms Overweight Rating for LifeStance Health Group (NASDAQ:LFST)

Morgan Stanley reiterated their overweight rating on shares of LifeStance Health Group (NASDAQ:LFST – Free Report) in a research report released on Monday morning, Benzinga reports. They currently have a $10.00 target price on the stock. Several other research analysts also recently weighed in on LFST. Jefferies Financial Group upped their target price on shares […]

Related Keywords

United States ,Kevin Michael Mullins ,Brown Advisory Inc ,Lifestance Health Group Inc ,Morgan Stanley ,Assetmark Inc ,Analyst Recommendations For Lifestance Health Group ,Lifestance Health Group Stock Performance ,News Ratings For Lifestance Health Group Daily ,Principal Financial Group Inc ,Charles Schwab Investment Management Inc ,Securities Exchange Commission ,Goldman Sachs Group ,Stratos Wealth Partners ,Lifestance Health Group ,Barclays ,Jefferies Financial Group ,Free Report ,Financial Group ,Stance Health Group ,Get Free Report ,Exchange Commission ,Schwab Investment Management ,Lifestance Health Group Daily ,Nasdaq Lfst ,Gulfst ,Medical ,Reiterated Rating ,